Texas invests $50M in psychedelic drug research to treat addiction
Texas has moved to fund research into ibogaine, a psychedelic drug that may help treat addiction, depression and brain injuries.
Jun 16, 2025
0
16
Heterocyclic Compounds: News and Research on Secologanin Tryptamine Alkaloids
MeSH tree: D03.633.100.473.402.681
Trials using psychedelic drug to treat trauma, addiction endorsed by Texas Legislature
U.S. Marine Cpl. Dakota Meyer, who once rescued three dozen people during a battle in the war-torn mountains of Afghanistan, was still in his 20s when the trauma came for him.
May 13, 2025
0
21
Repurposing a blood pressure drug may prevent vision loss in inherited blinding diseases
New studies in rats suggest the drug reserpine, approved in 1955 for high blood pressure, might treat the blinding disease retinitis pigmentosa. No therapy exists for this rare inherited disease, which starts affecting vision ...
Apr 15, 2025
0
16
Public voices often ignored in states' opioid settlement money decisions
The conversation wasn't sounding good for Kensington residents on June 20.
Aug 29, 2024
0
32
Psilocybin legislation is helping psychedelic drugs make a comeback
An operations manager finds relief from her depression with the help of psilocybin, the primary psychoactive component of "magic mushrooms." A veteran conquers his post-traumatic stress disorder through therapy using MDMA, ...
Aug 5, 2024
0
36
Could Colorado communities not friendly to medicinal mushrooms put up roadblocks to stymie the industry?
No city or town in Colorado is allowed to prohibit natural medicine healing centers from opening and offering supervised consumption of mushrooms and other psychedelics to adults—that much was plain in an initiative passed ...
Jul 23, 2024
0
25
Physical exercise prevents nerve damage during chemotherapy, sports scientist shows
Cancer treatments often cause nerve damage that can lead to long-lasting symptoms. Medication has proven ineffective in these cases. A sports scientist at the University of Basel, together with an interdisciplinary team from ...
Jul 1, 2024
0
60
New survey finds cancer drug shortage management remains a moving target, impacting clinical trials
The National Comprehensive Cancer Network (NCCN)—a nonprofit alliance of leading cancer centers—is publishing new results for its latest survey on cancer drug shortages in the United States. This follows data published one ...
Jun 26, 2024
0
21
Scientists propose therapeutic approach for inflammatory bowel disease
In a study published in Cell Host & Microbe, a research team has demonstrated the causal link between microbial factors and dysfunction of intestinal stem cells (ISCs) in colitis. On the basis of this mechanism, they proposed ...
May 24, 2024
0
44
Unraveling the roles of non-coding DNA explains childhood cancer's resistance to chemotherapy
St. Jude Children's Research Hospital scientists have identified specific DNA variants in the non-coding regions of the genome contributing to chemotherapy resistance in acute lymphoblastic leukemia (ALL). The results guided ...
May 1, 2024
0
56
